Topics

How Social Media Can Be Used to Understand What Matters to People with Rare Diseases

10:24 EDT 29 Apr 2019 | Pharma-Voice

Evidera has released a white paper related to the January FDA revised draft guidance on rare and orphan drug development. The use of social media is recommended to help make the drug development process more efficient. This includes identifying rare disease patients for clinical trials, and learning more about the unmet needs, disease burden, opinions, […]

The post How Social Media Can Be Used to Understand What Matters to People with Rare Diseases appeared first on PharmaVOICE.

Original Article: How Social Media Can Be Used to Understand What Matters to People with Rare Diseases

NEXT ARTICLE

More From BioPortfolio on "How Social Media Can Be Used to Understand What Matters to People with Rare Diseases"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...